VEGFA and eye disorder: Early research has indeed demonstrated that intravitreal nanoceria can decrease pathological neovascularization (by reducing VEGF levels) in eye disease models [142], hinting that an AMT-nanoceria hybrid could modulate the wound microenvironment in favor of regeneration over chronic inflammation.